152 related articles for article (PubMed ID: 34999051)
1. Inhibition of histone demethylase KDM4 by ML324 induces apoptosis through the unfolded protein response and Bim upregulation in hepatocellular carcinoma cells.
Kim SY; Hwang S; Lee BR; Hong JA; Sung YH; Kim I
Chem Biol Interact; 2022 Feb; 353():109806. PubMed ID: 34999051
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms underlying the effects of the small molecule AMC-04 on apoptosis: Roles of the activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway.
Kim SY; Hwang S; Choi MK; Park S; Nam KY; Kim I
Chem Biol Interact; 2020 Dec; 332():109277. PubMed ID: 33007289
[TBL] [Abstract][Full Text] [Related]
3. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
Yang JF; Cao JG; Tian L; Liu F
Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448
[TBL] [Abstract][Full Text] [Related]
4. Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells.
Liu G; Su L; Hao X; Zhong N; Zhong D; Singhal S; Liu X
J Cell Mol Med; 2012 Jul; 16(7):1618-28. PubMed ID: 21801305
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
[TBL] [Abstract][Full Text] [Related]
6. Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5, Bim, and PUMA expression in human carcinoma caki cells.
Jung KJ; Min KJ; Bae JH; Kwon TK
Oncotarget; 2015 Jan; 6(3):1556-68. PubMed ID: 25596735
[TBL] [Abstract][Full Text] [Related]
7. Silencing the epigenetic silencer KDM4A for TRAIL and DR5 simultaneous induction and antitumor therapy.
Wang J; Wang H; Wang LY; Cai D; Duan Z; Zhang Y; Chen P; Zou JX; Xu J; Chen X; Kung HJ; Chen HW
Cell Death Differ; 2016 Nov; 23(11):1886-1896. PubMed ID: 27612013
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
Bayo J; Fiore EJ; Dominguez LM; Real A; Malvicini M; Rizzo M; Atorrasagasti C; García MG; Argemi J; Martinez ED; Mazzolini GD
J Hepatol; 2019 Jul; 71(1):78-90. PubMed ID: 30880225
[TBL] [Abstract][Full Text] [Related]
9. PKCδ regulates death receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis in human lung cancer cells.
Xu L; Su L; Liu X
Mol Cancer Ther; 2012 Oct; 11(10):2174-82. PubMed ID: 22848091
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells.
Lee JY; Jung KH; Morgan MJ; Kang YR; Lee HS; Koo GB; Hong SS; Kwon SW; Kim YS
Mol Cancer Ther; 2013 Mar; 12(3):274-85. PubMed ID: 23053497
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of eIF2α dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells.
Teng Y; Gao M; Wang J; Kong Q; Hua H; Luo T; Jiang Y
Cell Death Dis; 2014 Feb; 5(2):e1060. PubMed ID: 24525736
[TBL] [Abstract][Full Text] [Related]
12. Effects of miR-155 on proliferation and apoptosis by regulating FoxO3a/BIM in liver cancer cell line HCCLM3.
Liao WW; Zhang C; Liu FR; Wang WJ
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1277-1285. PubMed ID: 29565484
[TBL] [Abstract][Full Text] [Related]
13. 6-Shogaol induces apoptosis in human hepatocellular carcinoma cells and exhibits anti-tumor activity in vivo through endoplasmic reticulum stress.
Hu R; Zhou P; Peng YB; Xu X; Ma J; Liu Q; Zhang L; Wen XD; Qi LW; Gao N; Li P
PLoS One; 2012; 7(6):e39664. PubMed ID: 22768104
[TBL] [Abstract][Full Text] [Related]
14. Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells.
Liu X; Guo S; Liu X; Su L
Apoptosis; 2015 Nov; 20(11):1499-507. PubMed ID: 26349783
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
[TBL] [Abstract][Full Text] [Related]
16. Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway.
Yi L; Zongyuan Y; Cheng G; Lingyun Z; Guilian Y; Wei G
Cancer Sci; 2014 May; 105(5):520-7. PubMed ID: 24612139
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
[TBL] [Abstract][Full Text] [Related]
18. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
Wang JG; Zheng XX; Zeng GY; Zhou YJ; Yuan H
Oncol Rep; 2014 Jan; 31(1):488-96. PubMed ID: 24247909
[TBL] [Abstract][Full Text] [Related]
19. A synthetic chalcone, 2'-hydroxy-2,3,5'-trimethoxychalcone triggers unfolded protein response-mediated apoptosis in breast cancer cells.
Lee DH; Jung Jung Y; Koh D; Lim Y; Lee YH; Shin SY
Cancer Lett; 2016 Mar; 372(1):1-9. PubMed ID: 26742460
[TBL] [Abstract][Full Text] [Related]
20. The farnesyltransferase inhibitor lonafarnib induces CCAAT/enhancer-binding protein homologous protein-dependent expression of death receptor 5, leading to induction of apoptosis in human cancer cells.
Sun SY; Liu X; Zou W; Yue P; Marcus AI; Khuri FR
J Biol Chem; 2007 Jun; 282(26):18800-9. PubMed ID: 17493934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
